Cambridge Investment Research Advisors, Inc. Amarin Corp Plcuk Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 12,542 shares of AMRN stock, worth $130,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,542
Previous 10,342
21.27%
Holding current value
$130,813
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding AMRN
# of Institutions
178Shares Held
71.2MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$259 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$129 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$46 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$26.2 Million5.52% of portfolio
-
Scp Investment, LP2.5MShares$26.1 Million1.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.21B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...